Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers

Author(s):
Beek, E.T. te; Hay, J.L.; Bullman, J.N.; Burgess, C.; Nahon, K.J.; Klaassen, E.S.; Gray, F.A.; Gerven, J.M.A. van (0000-0002-1444-7415)
Published
2013
Publication type
Article / Letter to editor
alcoholGSK1144814interactionNK1 receptorNK3 receptortachykinins
Date issued
2013-05-31
Language
English
Is part of
British Journal of Clinical Pharmacology (2013), Vol. 75, no. 5, p. 1328-1339
hdl
1887/102333
doi
10.1111/bcp.12004